Metacafe Header Takeover

PROMUS Element Stent

Tags:
Boston Scientific Promus Element Everolimus-Eluting Coronary Stent System Platinum Chromium
MultiVu
  • By: MultiVu
  • Subscribers: 67
  • Updated: 26-Nov-09
  • Videos: 2022
  • International International
  • Comments: 0
  • Views: 20
  • Added: 02-Nov-09

Boston Scientific Corporation (NYSE: BSX) today announced it has received CE Mark for its PROMUS® Element™ Everolimus-Eluting Coronary Stent System, the Company’s third-generation drug-eluting stent (DES) technology. The PROMUS Element system incorporates a unique platinum chromium alloy with an innovative stent design and an advanced catheter delivery system.

To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/bostonscientific/36501/

  1. Categories: Science & Tech
Comments on

PROMUS Element Stent

0 Comments | Be the first to comment